Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 45
Filter
Add more filters










Publication year range
1.
Bioconjug Chem ; 5(1): 98-100, 1994.
Article in English | MEDLINE | ID: mdl-7515281

ABSTRACT

The linking of amino haptens to carboxymethyldextran (CMD) requires carboxyl activation, for example, via carbodiimdes. We have discovered that substantial N-acylurea, derived from these carbodiimides, can be trapped on the CMD backbone. As an alternative, CMD can be conveniently lactonized by heating in inert solvents, and this carboxymethyldextran lactone (CLD) can be employed directly for amine conjugation.


Subject(s)
Amines/chemistry , Dextrans/chemical synthesis , Drug Carriers/chemical synthesis , Lactones/chemical synthesis , Polymers/chemical synthesis
2.
J Leukoc Biol ; 54(2): 138-44, 1993 Aug.
Article in English | MEDLINE | ID: mdl-7689628

ABSTRACT

Psoralens, together with ultraviolet light A (PUVA), are used for the treatment of several proliferative diseases. It has been suggested that the effectiveness of this treatment is due to induction of a specific immune response by PUVA-treated lymphocytes that down-regulates untreated cells of the same specificity. The present studies show that the clinically used psoralen analogue 8-methoxypsoralen (8-MOP), as well as 4,8-dimethyl-5'-(pyridiniummethyl)psoralen bromide (4NQ), a derivative that does not cross the cell membrane, when activated by UVA light, render lymphocytes unresponsive to mitogenic, antigenic, or phorbol myristate acetate + ionomycin-induced stimulation. This state of unresponsiveness was not reversed by exogenous recombinant interleukin-2. Treatment of lymphocytes with 4NQ and UVA light had no effect on the viability or the homing pattern of the cells to spleen or liver, whereas 8-MOP induced toxicity in about 50% of cells after 3 days in culture. Using an adoptive transfer mouse model, we found that antigen-specific lymphocytes treated with PUVA (8-MOP or 4NQ) had no effect on the ability of these mice to respond to a subsequent challenge with the same or an irrelevant antigen. This was tested by measuring the T cell proliferative responses of lymph node cells from mice primed with keyhole limpet hemocyanin (KLH) or fowl gamma globulin (FGG) before or after adoptive transfer of large numbers of KLH- or FGG-specific PUVA-treated lymph node cells. No effects of antigen-primed PUVA-treated cells on antigen-primed untreated cells were observed in vitro in mixed lymphocyte cultures responding to the relevant antigen. These results suggest that, in our model system, PUVA induces cell inactivation but does not affect systemic T cell responses.


Subject(s)
Immunity/drug effects , Lymphocytes/drug effects , PUVA Therapy , Animals , Antigens/immunology , Cell Survival/drug effects , Epitopes , Immunotherapy, Adoptive , In Vitro Techniques , Interleukin-2/pharmacology , Lymphocyte Activation/drug effects , Male , Mice , Mice, Inbred C3H , Recombinant Proteins/pharmacology , T-Lymphocytes/drug effects
3.
Anal Biochem ; 202(1): 6-9, 1992 Apr.
Article in English | MEDLINE | ID: mdl-1320351

ABSTRACT

An enzymatic cycling procedure for beta-NADP+ generated by the enzyme 3'-phosphodiesterase, 2':3'-cyclic nucleotide (EC 3.1.4.37) from its substrate 2':3'-cyclic NADP+ is described. The enzymes glucose-6-phosphate dehydrogenase (EC 1.1.1.49) and diaphorase (EC 1.8.1.4) are used to cycle the cofactor between its oxidized and reduced forms in the presence of glucose-6-phosphate and p-iodonitrotetrazolium violet (INT) with the concomitant production of colored INT-formazan, monitored at 492 nm. The amplification is about 400-fold per hour and is sensitive enough to detect 6 x 10(-13) mol of NADP(H). A simple procedure for the optimization of this cycling assay is also described. Conjugates to 3'-phosphodiesterase, 2':3'-cyclic nucleotide may be used in heterogeneous enzyme immunoassays for the detection of small quantities of haptens or proteins in biological fluids.


Subject(s)
2',3'-Cyclic-Nucleotide Phosphodiesterases/metabolism , NADP/metabolism , Phosphoric Diester Hydrolases , 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase , Dihydrolipoamide Dehydrogenase/metabolism , Glucosephosphate Dehydrogenase/metabolism , Kinetics , Oxidation-Reduction , Sensitivity and Specificity , Spectrophotometry, Ultraviolet , Tetrazolium Salts/chemistry
4.
Bioconjug Chem ; 2(6): 427-30, 1991.
Article in English | MEDLINE | ID: mdl-1725255

ABSTRACT

A maleimide hydrazide has been synthesized as a heterobifunctional cross-linking agent for thiol to formyl coupling. This linker has been applied to the coupling of the monoclonal antibody 17-1A, or an Fab' derived therefrom, to polyaldehyde dextran onto which the antineoplastic agent ellipticine has been attached. High binding avidities for the unshed antigen on the SW1116 colorectal tumor cell are retained in these drug-dextran-linker-antibody conjugates.


Subject(s)
Antibodies, Monoclonal , Antigens, Neoplasm/immunology , Cross-Linking Reagents/chemistry , Formates/chemistry , Immunoglobulin Fab Fragments , Maleic Hydrazide/chemistry , Sulfhydryl Compounds/chemistry , Benzaldehydes/chemistry , Colorectal Neoplasms/immunology , Cross-Linking Reagents/chemical synthesis , Dextrans/chemistry , Ellipticines/chemistry , Hydrazones/chemistry , Molecular Structure , Tumor Cells, Cultured
5.
J Pharm Sci ; 80(7): 686-9, 1991 Jul.
Article in English | MEDLINE | ID: mdl-1941569

ABSTRACT

An exchange hydrogenation reaction on trioxsalen yields two isomeric dihydro analogues for which a combined HPLC-supercritical fluid chromatography method supplies purified materials. These reduced compounds and a related benzodipyranone are biologically active and inhibit the binding of epidermal growth factor on HeLa cells to an even greater extent than trioxsalen. This observation suggests a non-DNA target may play a role in the overall effects of psoralens on cells.


Subject(s)
Epidermal Growth Factor/metabolism , Furocoumarins/chemical synthesis , Binding, Competitive/drug effects , Chromatography, High Pressure Liquid , Furocoumarins/pharmacology , HeLa Cells , Humans , Indicators and Reagents , Iodine Radioisotopes , Spectrophotometry, Ultraviolet
6.
Pharm Res ; 8(3): 400-2, 1991 Mar.
Article in English | MEDLINE | ID: mdl-1711201

ABSTRACT

Colorimetric or potentiometric titration of the aldehyde residues in polyaldehyde dextran by the hydroxylamine hydrochloride/sodium hydroxide method has been found to be a convenient and accurate method to determine formyl content. Nitrogen combustion analyses on the isolated oximes confirmed the titrametric results.


Subject(s)
Dextrans/analysis , Hydroxylamines , Aldehydes/analysis , Colorimetry/methods , Hydroxylamine , Hydroxylamines/analysis , Nitrogen/analysis , Potentiometry/methods
7.
J Pharm Sci ; 79(10): 862-5, 1990 Oct.
Article in English | MEDLINE | ID: mdl-2280352

ABSTRACT

A new class of radiosensitizing pharmaceuticals derived from 4-nitro-5-imidazolyl sulfones has its clinical potential compromised by a metabolic reaction with plasma glutathione which leads to a much less active metabolite. Entrapment of two members of the class in three different liposomes, one polymerized liposome, and a beta-cyclodextrin system has shown that this glutathione condensation can be suppressed by a rate factor of nearly 50-fold. Stabilizations of these metabolically labile radiosensitizers appear to relate to their lipid-buffer partition coefficients and to the fluidity of the liposome membrane in which they are entrapped.


Subject(s)
Cyclodextrins/chemistry , Glutathione/chemistry , Liposomes/chemistry , Nitroimidazoles/chemistry , Radiation-Sensitizing Agents/chemistry , Sulfones/chemistry , beta-Cyclodextrins , 2-Hydroxypropyl-beta-cyclodextrin , Half-Life , Kinetics , Spectrophotometry, Ultraviolet
8.
Bioconjug Chem ; 1(5): 314-8, 1990.
Article in English | MEDLINE | ID: mdl-2098108

ABSTRACT

The radiation sensitizer misonidazole has been linked to the monoclonal antibody 17-1A which recognizes a nonshed antigen of a human gastrointestinal tumor. Linkage was accomplished through a hemisuccinate of misonidazole attached by a mixed anhydride coupling and gave a conjugate whose plasma half-life (for drug cleavage) was ca. 70 h. The degree of substitution on the antibody could be precisely regulated by varying the reactant ratios. The binding avidities of the resulting conjugates to the SW1116 colorectal tumor cells decrease logarithmically with increasing drug load. Four to six misonidazoles per antibody represented the optimum drug loading on this system. Enzymatic cleavage of the conjugate-drug union took place at both the ester and the amide linkages with the former scission predominating.


Subject(s)
Antibodies, Monoclonal , Antigens, Neoplasm/immunology , Colonic Neoplasms/immunology , Immunotoxins , Misonidazole , Adenocarcinoma/immunology , Aged , Chromatography, High Pressure Liquid , Drug Stability , Half-Life , Humans , Immunotoxins/blood , Immunotoxins/pharmacokinetics , Male , Misonidazole/administration & dosage , Misonidazole/pharmacokinetics , Tumor Cells, Cultured
9.
Bioconjug Chem ; 1(1): 77-82, 1990.
Article in English | MEDLINE | ID: mdl-1710144

ABSTRACT

The coupling of ellipticine and CI-921, two antineoplastic pharmaceuticals, to polyaldehyde dextran can be carried out under mild reaction conditions with novel acid hydrazides of the parent drugs. The resulting acyl hydrazones resist hydrolytic and enzymatic cleavage and offer a method for drug loading via dextran conjugates to monoclonal antibodies.


Subject(s)
Amsacrine/analogs & derivatives , Antineoplastic Agents , Dextrans/chemical synthesis , Ellipticines , Ellipticines/chemical synthesis , Hydrazones/chemical synthesis , Amsacrine/chemical synthesis , Amsacrine/chemistry , Animals , Dextrans/chemistry , Drug Stability , Ellipticines/chemistry , Enzymes/blood , Hydrazones/chemistry , Hydrolysis , Indicators and Reagents , Rats
10.
Radiat Res ; 117(1): 47-58, 1989 Jan.
Article in English | MEDLINE | ID: mdl-2913608

ABSTRACT

Misonidazole, a clinically-effective 2-nitroimidazole hypoxic cell radiation sensitizer, and 12 4-nitro-5-sulfonatoimidazoles were tested in cultured human SW1116 colorectal adenocarcinoma cells for radiosensitizing efficiency. Octanol-water partition coefficients and HPLC capacity factors were determined for all agents as measurements of lipophilicity, and an excellent correlation was found between the two measurements. Cytotoxicity, in vitro glutathione reactivity, and one-electron reduction potential were also determined for each compound to evaluate potential utility as macromolecularly transported radiosensitizers. Ten members of the set were found to be 40 to 300 times more radiotoxic than misonidazole, but no correlation was found between their radiosensitizing efficiencies and the chemical and physical parameters.


Subject(s)
Colorectal Neoplasms/pathology , Nitroimidazoles/pharmacology , Radiation-Sensitizing Agents/pharmacology , Tumor Cells, Cultured/drug effects , Adenocarcinoma/pathology , Cell Line , Cell Survival/drug effects , Cell Survival/radiation effects , Humans , In Vitro Techniques , Misonidazole/pharmacology , Tumor Cells, Cultured/radiation effects
13.
Cancer Res ; 47(15): 4071-5, 1987 Aug 01.
Article in English | MEDLINE | ID: mdl-3496956

ABSTRACT

Misonidazole was covalently conjugated (3-68 mol drug/mol antibody) to 19-9 monoclonal antibody directed against a colorectal carcinoma tumor-associated antigen as a method for targeting radiosensitizing agents. This attachment was accomplished by the mixed anhydride method using the hemisuccinate derivative of misonidazole. Evaluation of conjugates in vitro shows a loss of antibody binding activity with increasing loading levels; however, significant binding activity is retained even at relatively high sensitizer/antibody ratios. This observation was consistent in three binding assays: a competitive radioimmunoassay; an enzyme immunoassay; and an affinity column assay. From these studies, it was concluded that the optimal loading factor for misonidazole-antibody conjugates, when it is used for immunochemotherapy lies between 8 and 15. In vitro release studies indicated that conjugates are hydrolytically stable (t1/2 = 4 days) under physiological conditions.


Subject(s)
Antigens, Neoplasm/immunology , Immunotoxins , Misonidazole , Antibodies, Monoclonal/immunology , Antibodies, Neoplasm/immunology , Antigen-Antibody Reactions , Antigens, Tumor-Associated, Carbohydrate , Chromatography, Affinity , Colonic Neoplasms/immunology , Enzyme-Linked Immunosorbent Assay , Immunoglobulin G/immunology , Immunotoxins/chemical synthesis , Radioimmunoassay , Rectal Neoplasms/immunology
14.
J Pharm Sci ; 76(5): 384-6, 1987 May.
Article in English | MEDLINE | ID: mdl-2443638

ABSTRACT

4-Nitro-5-sulfonylimidazoles represent a class of hypoxic cell radiation sensitizers whose in vitro activity greatly exceeds that of the current clinical standard, misonidazole. However, in vivo studies with these 4,5-disubstituted imidazoles have shown that a rapid reaction with circulating thiols decomposes the agent and compromises its clinical utility. Drug-macromolecule conjugates prepared in this study from poly-L-glutamate, succinylated poly-L-lysine, dextran, and a succinylated polylysine-antibody, all demonstrated protection of the drug from glutathione displacement. 1-Methyl-4-nitro-5-imidazolyl 4-aminophenyl sulfone conjugated to a succinylated poly-L-lysine-antibody was greater than 7 times less reactive than the unbound drug. Polymer transport may offer a useful tumor-delivery mechanism for these highly reactive radiation sensitizers.


Subject(s)
Nitroimidazoles , Radiation-Sensitizing Agents , Sulfones , Antibodies, Monoclonal , Antigens, Neoplasm/immunology , Antigens, Surface/immunology , Chemical Phenomena , Chemistry , Dextrans , Glutathione , Macromolecular Substances , Polyglutamic Acid , Polylysine/analogs & derivatives , Succinates
15.
J Pharm Sci ; 73(3): 394-6, 1984 Mar.
Article in English | MEDLINE | ID: mdl-6716250

ABSTRACT

Three families of alloxan derivatives, 5-arylthiobarbituric, 5-aryliminobarbituric, and 5-aryldialuric acids, were prepared as prospective radioiodine-transporting radiopharmaceuticals for the delineation of pancreatic insulinomas. Members of each class were screened for effects on blood sugar levels in a rat glucose tolerance assay. Transient hyperglycemia was observed with 5-(2,4-dichlorophenyl)iminobarbituric acid. No agent evaluated induced permanent diabetes at the doses tested.


Subject(s)
Alloxan/analogs & derivatives , Pancreas/diagnostic imaging , Alloxan/chemical synthesis , Animals , Blood Glucose/metabolism , Glucose Tolerance Test , Male , Radionuclide Imaging , Rats , Rats, Inbred Strains
17.
J Pharm Sci ; 71(11): 1223-6, 1982 Nov.
Article in English | MEDLINE | ID: mdl-7175713

ABSTRACT

111In-labeled tetra(4-N-methylpyridyl)porphyrin was investigated as a possible lymph node imaging agent. A clinically feasible method for the preparation of this radioactive pharmaceutical was developed from experiments with the synthesis and characterization of the unlabeled complex. The in vivo distribution of the compound in Wistar rats was determined as a function of time. Favorable lymph node-blood, lymph node-muscle, and specific lymph node-surrounding tissue ratios were obtained.


Subject(s)
Indium , Lymph Nodes/diagnostic imaging , Mesoporphyrins , Porphyrins , Radioisotopes , Animals , Isotope Labeling , Radionuclide Imaging , Rats , Rats, Inbred Strains , Time Factors , Tissue Distribution
19.
J Pharm Sci ; 70(1): 84-6, 1981 Jan.
Article in English | MEDLINE | ID: mdl-7229935

ABSTRACT

Nine new alpha-methylene-gamma-butyrolactones were synthesized by the Reformatsky condensation of ethyl alpha-bromomethylacrylate with ketones, aldehydes, and an epoxide. A unique spirobutyrolactone class was prepared by reaction of the zinc alkyl derivative and N-methylisatins. The compounds were evaluated against L-1210 and P-388 leukemia and the 9KB carcinoma of the nasopharynx. They also were screened in a microbiocidal and an antifungal assay. The spiro methylene lactone of 5-iodo-N-methylisatin displayed activity in the P-388, 9KB, and antifungal screens.


Subject(s)
4-Butyrolactone/pharmacology , Anti-Bacterial Agents , Antineoplastic Agents , Furans/pharmacology , 4-Butyrolactone/analogs & derivatives , 4-Butyrolactone/chemical synthesis , Animals , Antifungal Agents , Cells, Cultured , Drug Evaluation, Preclinical , Humans , Leukemia L1210/drug therapy , Leukemia P388/drug therapy , Mice , Nasopharyngeal Neoplasms/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...